NCT00005943
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- University of Colorado Denver, Colorado, United States
Clinical trial condition
Melanoma (Skin)
Explore clinical trials studying Melanoma (Skin). Study availability and eligibility vary by location and protocol.
255 public trials
14 recruiting studies
Melanoma (Skin) trial results
NCT00346008
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Iceland Genomics Corporation Reykjavik, Iceland
NCT00005968
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- John Wayne Cancer Institute Santa Monica, California, United States
- Veterans Affairs Medical Center - Denver Denver, Colorado, United States
- University of Colorado Cancer Center Denver, Colorado, United States
- Lutheran General Hospital Park Ridge, Illinois, United States
NCT00095953
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada
- Fraser Valley Cancer Centre at British Columbia Cancer Agency Surrey, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Cancer Centre Vancouver, British Columbia, Canada
- Nova Scotia Cancer Centre at Queen Elizabeth II Health Sciences Centre Halifax, Nova Scotia, Canada
NCT00006368
- Conditions
- Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +105 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00004184
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
Not specified
NCT00085423
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT00568048
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Kantonsspital Graubuenden Chur, Switzerland
Completed
PEG-Interferon Alfa-2b and Thalidomide in Treating Patients With Recurrent or Metastatic Melanoma
NCT00238329
- Conditions
- Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +16 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Completed
Biological Therapy Following Surgery in Treating Patients With Stage III or Stage IV Melanoma
NCT00004022
- Conditions
- Melanoma, Melanoma (Skin), Neoplasms, +10 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States